LUMOS PHARMA, INC. Annual Return On Assets in % from 2012 to 2023

Taxonomy & unit
ratio: %
Description
Return on assets can be defined as an indicator of how profitable a company is relative to its total assets. Calculated by dividing a company's operating earnings by its total assets.
Summary
Lumos Pharma, Inc. quarterly/annual Return On Assets history and growth rate from 2012 to 2023.
  • Lumos Pharma, Inc. Return On Assets for the quarter ending June 30, 2024 was -104 %, a 122% decline year-over-year.
  • Lumos Pharma, Inc. annual Return On Assets for 2023 was -65.3 %, a 73.5% decline from 2022.
  • Lumos Pharma, Inc. annual Return On Assets for 2022 was -37.6 %, a 36.4% decline from 2021.
  • Lumos Pharma, Inc. annual Return On Assets for 2021 was -27.6 %, a 656% decline from 2020.
Return On Assets, Annual (%)
Return On Assets, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date
2023 -65.3 -27.7 -73.5% Jan 1, 2023 Dec 31, 2023
2022 -37.6 -10 -36.4% Jan 1, 2022 Dec 31, 2022
2021 -27.6 -23.9 -656% Jan 1, 2021 Dec 31, 2021
2020 -3.65 +7.06 +65.9% Jan 1, 2020 Dec 31, 2020
2019 -10.7 +26 +70.9% Jan 1, 2019 Dec 31, 2019
2018 -36.8 +10.7 +22.6% Jan 1, 2018 Dec 31, 2018
2017 -47.5 -1.48 -3.22% Jan 1, 2017 Dec 31, 2017
2016 -46 -29 -170% Jan 1, 2016 Dec 31, 2016
2015 -17 -94.9 -122% Jan 1, 2015 Dec 31, 2015
2014 77.8 +124 Jan 1, 2014 Dec 31, 2014
2013 -46.2 +17.3 +27.2% Jan 1, 2013 Dec 31, 2013
2012 -63.5 Jan 1, 2012 Dec 31, 2012
* An asterisk sign (*) next to the value indicates that the value is likely invalid.